Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody signatures against viruses and microbiome reflect past and chronic exposures and associate with aging and inflammation.
Andreu-Sánchez S, Ripoll-Cladellas A, Culinscaia A, Bulut O, Bourgonje AR, Netea MG, Lansdorp P, Aubert G, Bonder MJ, Franke L, Vogl T, van der Wijst MGP, Melé M, Van Baarle D, Fu J, Zhernakova A. Andreu-Sánchez S, et al. Among authors: van baarle d. iScience. 2024 May 16;27(6):109981. doi: 10.1016/j.isci.2024.109981. eCollection 2024 Jun 21. iScience. 2024. PMID: 38868191 Free PMC article.
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination.
Geers D, Sablerolles RSG, van Baarle D, Kootstra NA, Rietdijk WJR, Schmitz KS, Gommers L, Bogers S, Nieuwkoop NJ, van Dijk LLA, van Haren E, Lafeber M, Dalm VASH, Goorhuis A, Postma DF, Visser LG, Huckriede ALW, Sette A, Grifoni A, de Swart RL, Koopmans MPG, van der Kuy PHM, GeurtsvanKessel CH, de Vries RD; SWITCH research group. Geers D, et al. Among authors: van haren e, van dijk lla, van baarle d, van der kuy phm. iScience. 2023 Jan 20;26(1):105753. doi: 10.1016/j.isci.2022.105753. Epub 2022 Dec 7. iScience. 2023. PMID: 36507223 Free PMC article.
Profiling the fecal microbiome and its modulators across the lifespan in the Netherlands.
Boverhoff D, Kool J, Pijnacker R, Ducarmon QR, Zeller G, Shetty S, Sie S, Mulder AC, van der Klis F, Franz E, Mughini-Gras L, van Baarle D, Fuentes S. Boverhoff D, et al. Among authors: van baarle d. Cell Rep. 2024 Sep 24;43(9):114729. doi: 10.1016/j.celrep.2024.114729. Epub 2024 Sep 11. Cell Rep. 2024. PMID: 39264809 Free article.
Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses.
den Hartog Y, Malahe SRK, Rietdijk WJR, Dieterich M, Gommers L, Geers D, Bogers S, van Baarle D, Diavatopoulos DA, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Bemelman FJ, Gansevoort RT, Hilbrands LB, Sanders JS, GeurtsvanKessel CH, Kho MML, Reinders MEJ, de Vries RD, Baan CC; RECOVAC Consortium. den Hartog Y, et al. Among authors: van der molen rg, van baarle d. NPJ Vaccines. 2023 May 17;8(1):70. doi: 10.1038/s41541-023-00664-4. NPJ Vaccines. 2023. PMID: 37198189 Free PMC article.
SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Imhof C, Messchendorp AL, van der Heiden M, Baan CC, van der Molen RG, Remmerswaal EBM, de Vries RD, Diavatopoulos DA, Boerma A, Bakker FJ, Oosterhout E, Bemelman FJ, Hilbrands LB, Reinders MEJ, Gansevoort RT, Sanders JS, van Baarle D. Imhof C, et al. Among authors: van der heiden m, van der molen rg, van baarle d. Transplant Direct. 2022 Oct 18;8(11):e1387. doi: 10.1097/TXD.0000000000001387. eCollection 2022 Nov. Transplant Direct. 2022. PMID: 36284929 Free PMC article.
Effect of DMARDs on the immunogenicity of vaccines.
van Sleen Y, van der Geest KSM, Huckriede ALW, van Baarle D, Brouwer E. van Sleen Y, et al. Among authors: van der geest ksm, van baarle d. Nat Rev Rheumatol. 2023 Sep;19(9):560-575. doi: 10.1038/s41584-023-00992-8. Epub 2023 Jul 12. Nat Rev Rheumatol. 2023. PMID: 37438402 Review.
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Kho MML, Messchendorp AL, Frölke SC, Imhof C, Koomen VJ, Malahe SRK, Vart P, Geers D, de Vries RD, GeurtsvanKessel CH, Baan CC, van der Molen RG, Diavatopoulos DA, Remmerswaal EBM, van Baarle D, van Binnendijk R, den Hartog G, de Vries APJ, Gansevoort RT, Bemelman FJ, Reinders MEJ, Sanders JF, Hilbrands LB; RECOVAC collaborators. Kho MML, et al. Among authors: van der molen rg, van binnendijk r, van baarle d. Lancet Infect Dis. 2023 Mar;23(3):307-319. doi: 10.1016/S1473-3099(22)00650-8. Epub 2022 Oct 27. Lancet Infect Dis. 2023. PMID: 36354032 Free PMC article. Clinical Trial.
233 results